A nurse holds a COVID-19 vaccine in Miami, Fla., in this file photograph. Joe Raedle/Getty ImagesPfizer reported a decline in revenue on Nov. 4, which it primarily attributed to lower sales for the company’s COVID-19 vaccine, Comirnaty, and COVID-19 drug, Paxlovid.The company said it made $16.7 billion in revenue in the third quarter, down 7 percent from Q3 2024.
Date:
More like thisRelated
Major Investor to Vote Against $1 Trillion Elon Musk Pay Package
Elon Musk attends the opening ceremony of the new...
Rapper RBX Sues Spotify, Alleging Billions of Drakes Streams Are Fraudulent
The Spotify app on an iPad in Baltimore on...
US Lawmakers Urge Cancellation of CCP Super Embassy in London
Protesters demonstrate at the proposed site of a new...